tm logo

Monitor this mark

View On USPTO

INTERCEPT
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 22 Feb 2023

Last Applicant/ Owned by

Intercept Pharmaceuticals, Inc.

305 Madison Avenue

Morristown

NJ

07960

Serial Number

86424518 filed on 15th Oct 2014

Registration Number

5055185 registered on 04th Oct 2016

in the Principal Register

Correspondent Address

Jennifer Sheehan Anderson

Jennifer Sheehan Anderson

143 CadyCenter, Suite 209

Northville MI 48167

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

INTERCEPT

House mark for pharmaceutical preparations used to treat chronic liver and intestinal diseases

Classification Information

Class [005]
Pharmaceutical Products

House mark for pharmaceutical preparations used to treat chronic liver and intestinal diseases

First Use Date in General

31st Jul 2012

First Use Date in Commerce

31st May 2016

Mark Details

Serial Number

No 86424518

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 715.364464

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.13.13 -

Two quadrilaterals

26.13.21 -

Quadrilaterals that are completely or partially shaded

Legal History

Show more

Status DateAction Taken
23rd Feb 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
22nd Feb 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
22nd Feb 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08th Aug 2022TEAS SECTION 8 & 15 RECEIVED
04th Oct 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09th Sep 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
04th Oct 2016REGISTERED-PRINCIPAL REGISTER
30th Aug 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
29th Aug 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
22nd Aug 2016STATEMENT OF USE PROCESSING COMPLETE